MaxCyte, Inc. Share Price
MXCTMaxCyte, Inc. Stock Performance
Open $1.25 | Prev. Close $1.25 | Circuit Range N/A |
Day Range $1.22 - $1.29 | Year Range $0.65 - $2.37 | Volume 65,964 |
Average Traded $1.24 |
MaxCyte, Inc. Share Price Chart
About MaxCyte, Inc.
MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally. The company's products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. It also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. The company licenses and sells its instruments and technology; and sells its consumables to developers of cell therapies, as well as to pharmaceutical and biotechnology companies for use in drug discovery and development, and bio-manufacturing. MaxCyte, Inc. was incorporated in 1998 and is headquartered in Rockville, Maryland.
MaxCyte, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
29-Jun-26 | $1.25 | $1.25 | +0.00% |
29-Jun-26 | $1.25 | $1.25 | -0.40% |
26-Jun-26 | $1.28 | $1.25 | -0.79% |
25-Jun-26 | $1.25 | $1.26 | +5.88% |
24-Jun-26 | $1.21 | $1.19 | +1.28% |
23-Jun-26 | $1.21 | $1.18 | -0.42% |
22-Jun-26 | $1.23 | $1.18 | -1.67% |